CD40LG and polycystic ovary syndrome: A statistically significant elevation of cardiovascular risk markers like sCD40L, ADMA along with Hcy levels in the studies by Oktem et al. and Mohamadin et al. raises a question of whether to involve those markers in the routine clinical screening of PCOS to evaluate cardiovascular risk [13,21].